Table 4.
Cancer site family member | RR for in situ skin squamous cell cancer when family member had in situ cancer | RR for in situ cancer when family member had in situ skin squamous cell cancer | RR for skin squamous cell cancer when family member had in situ cancer | RR for in situ cancer when family member had skin squamous cell cancer | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Cases | RR | 95%CI | Cases | RR | 95%CI | Cases | RR | 95%CI | Cases | RR | 95%CI | |
Cervix | 1645 | 1.03 | 0.98–1.08 | 5966 | 0.93 | 0.91–0.96 | 1106 | 1.13 | 1.06–1.20 | 4201 | 0.98 | 0.95–1.02 |
Male | 806 | 1.04 | 0.97–1.12 | NR | 633 | 1.15 | 1.06–1.24 | NR | ||||
Female | 839 | 1.01 | 0.95–1.09 | As above | 473 | 1.10 | 1.00–1.21 | As above | ||||
Other female genital | 73 | 1.38 | 1.09–1.73 | 163 | 1.25 | 1.06–1.46 | 46 | 1.42 | 1.06–1.90 | 102 | 1.13 | 0.93–1.38 |
Male | 45 | 1.69 | 1.26–2.26 | NR | 28 | 1.51 | 1.04–2.19 | NR | ||||
Female | 28 | 1.06 | 0.73–1.53 | As above | 18 | 1.34 | 0.84–2.13 | As above | ||||
Upper aerodigestive tract | 74 | 1.48 | 1.18–1.86 | 72 | 1.33 | 1.05–1.69 | 44 | 1.49 | 1.11–2.00 | 55 | 1.44 | 1.10–1.89 |
Male | 35 | 1.45 | 1.04–2.01 | 46 | 1.31 | 0.98–1.77 | 26 | 1.56 | 1.06–2.29 | 24 | 0.96 | 0.64–1.45 |
Female | 39 | 1.52 | 1.11–2.08 | 26 | 1.35 | 0.91–2.00 | 18 | 1.40 | 0.88–2.23 | 31 | 2.33 | 1.62–3.35 |
Other male genital | 25 | 1.44 | 0.97–2.13 | 37 | 0.97 | 0.70–1.35 | 14 | 1.35 | 0.80–2.29 | 26 | 1.00 | 0.68–1.48 |
Male | 16 | 1.93 | 1.18–3.15 | As above | 9 | 1.57 | 0.82–3.01 | As above | ||||
Female | 9 | 0.99 | 0.52–1.90 | NR | 5 | 1.10 | 0.46–2.64 | NR | ||||
Colorectum | 482 | 1.03 | 0.94–1.13 | 651 | 0.93 | 0.86–1.00 | 296 | 1.06 | 0.94–1.18 | 427 | 0.86 | 0.78–0.95 |
Male | 227 | 0.98 | 0.86–1.11 | 352 | 0.87 | 0.78–0.97 | 172 | 1.07 | 0.92–1.25 | 249 | 0.88 | 0.77–0.99 |
Female | 255 | 1.08 | 0.95–1.22 | 299 | 1.00 | 0.89–1.13 | 124 | 1.04 | 0.87–1.24 | 178 | 0.84 | 0.72–0.97 |
Melanoma | 517 | 1.63 | 1.49–1.78 | 1371 | 1.59 | 1.51–1.68 | 296 | 1.54 | 1.38–1.73 | 896 | 1.50 | 1.40–1.60 |
Male | 250 | 1.59 | 1.40–1.80 | 651 | 1.56 | 1.44–1.69 | 159 | 1.45 | 1.24–1.70 | 442 | 1.53 | 1.39–1.68 |
Female | 267 | 1.67 | 1.48–1.88 | 720 | 1.62 | 1.50–1.75 | 137 | 1.67 | 1.41–1.97 | 454 | 1.47 | 1.34–1.62 |
Non-Hodgkin lymphoma | 28 | 1.17 | 0.81–1.70 | 40 | 1.09 | 0.79–1.50 | 19 | 1.33 | 0.85–2.09 | 25 | 0.97 | 0.65–1.44 |
Male | 12 | 1.03 | 0.59–1.82 | 26 | 1.20 | 0.81–1.79 | 11 | 1.36 | 0.75–2.45 | 13 | 0.85 | 0.49–1.48 |
Female | 16 | 1.31 | 0.80–2.14 | 14 | 0.93 | 0.54–1.58 | 8 | 1.30 | 0.65–2.61 | 12 | 1.14 | 0.64–2.03 |
All (including SCCa) | 6424 | 1.50 | 1.46–1.55 | 13348 | 1.18 | 1.16–1.20 | 3677 | 1.41 | 1.36–1.46 | 9009 | 1.17 | 1.14–1.19 |
Male | 3180 | 1.51 | 1.45–1.57 | 3099 | 1.56 | 1.51–1.62 | 2121 | 1.43 | 1.36–1.50 | 2060 | 1.47 | 1.41–1.54 |
Female | 3244 | 1.50 | 1.44–1.56 | 10249 | 1.10 | 1.08–1.12 | 1556 | 1.39 | 1.32–1.47 | 6949 | 1.10 | 1.07–1.12 |
SCCa = skin squamous cell cancer.
RR = relative risk, 95%CI = 95% confidence interval, bold font indicates that the lower limit of 95%CI does not include 1.00.